Search research articles
Contact Us
Filters
Showing results (201-210 of 219) with videos related to
Page
of 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 10, 2012
Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study
John M S Bartlett, Kenneth J Bloom, Tammy Piper, et al.
BMC Cancer
|
April 15, 2022
Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer
Harsha Ranganath, Amit L Jain, Justin R Smith, et al.
Plos One
|
October 13, 2018
Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
Kenichi Harano, Ying Wang, Bora Lim, et al.
The American Journal of Surgical Pathology
|
January 29, 2008
A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors
Inigo Espinosa, Cheng-Han Lee, Mi Kyung Kim, et al.
Metrologia
|
February 23, 2016
Metrological challenges for measurements of key climatological observables: Oceanic salinity and pH, and atmospheric humidity. Part 1: Overview
R Feistel, R Wielgosz, S A Bell, et al.
Scientific Reports
|
October 19, 2021
Visible blue light inhibits infection and replication of SARS-CoV-2 at doses that are well-tolerated by human respiratory tissue
Nathan Stasko, Jacob F Kocher, Abigail Annas, et al.
The Journal of Investigative Dermatology
|
March 28, 2008
Xeroderma pigmentosum-variant patients from America, Europe, and Asia
Hiroki Inui, Kyu-Seon Oh, Carine Nadem, et al.
British Journal of Cancer
|
June 9, 1999
European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium
V Launonen, K Laake, P Huusko, et al.
Cancer Research
|
March 21, 1998
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters
C M Phelan, A Borg, M Cuny, et al.
Genes, Chromosomes & Cancer
|
June 24, 1999
Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium
K Laake, V Launonen, D Niederacher, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 219) with videos related to
Sort By:
Page
of 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 10, 2012
Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study
John M S Bartlett, Kenneth J Bloom, Tammy Piper, et al.
BMC Cancer
|
April 15, 2022
Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer
Harsha Ranganath, Amit L Jain, Justin R Smith, et al.
Plos One
|
October 13, 2018
Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
Kenichi Harano, Ying Wang, Bora Lim, et al.
The American Journal of Surgical Pathology
|
January 29, 2008
A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors
Inigo Espinosa, Cheng-Han Lee, Mi Kyung Kim, et al.
Metrologia
|
February 23, 2016
Metrological challenges for measurements of key climatological observables: Oceanic salinity and pH, and atmospheric humidity. Part 1: Overview
R Feistel, R Wielgosz, S A Bell, et al.
Scientific Reports
|
October 19, 2021
Visible blue light inhibits infection and replication of SARS-CoV-2 at doses that are well-tolerated by human respiratory tissue
Nathan Stasko, Jacob F Kocher, Abigail Annas, et al.
The Journal of Investigative Dermatology
|
March 28, 2008
Xeroderma pigmentosum-variant patients from America, Europe, and Asia
Hiroki Inui, Kyu-Seon Oh, Carine Nadem, et al.
British Journal of Cancer
|
June 9, 1999
European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium
V Launonen, K Laake, P Huusko, et al.
Cancer Research
|
March 21, 1998
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters
C M Phelan, A Borg, M Cuny, et al.
Genes, Chromosomes & Cancer
|
June 24, 1999
Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium
K Laake, V Launonen, D Niederacher, et al.
Page
of 22